PHARMACY

FDA tenatively approves Teva pink eye generic

BY Alaric DeArment

ROCKVILLE, Md. The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its generic version of a drug for eye infections, FDA records showed.

The agency gave Teva the tentative approval for its moxifloxacin hydrochloride ophthalmic solution in the 0.5% strength. The solution is a generic version of Alcon’s Vigamox, which is used to treat bacterial conjunctivitis, commonly known as pink eye.

Alcon does not list the sales figures for Vigamox, though it reported sales of drugs to treat infections and inflammations of $882.5 million for 2008 in Securities and Exchange Commission filings.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Governments vie for GSK flu vaccine

BY Alaric DeArment

LONDON Several governments have placed orders with GlaxoSmithKline for a candidate vaccine for the A (H1N1) influenza virus, popularly known as swine flu, the British drug maker announced.

GSK said it will manufacture the new vaccine once the World Health Organization makes the virus seed available, and it expects the first doses to be available six months later.

As of Monday, the influenza strain had infected 5,123 people and caused five deaths in the United States, according to the Centers for Disease Control and Prevention. Many public health experts fear that the virus could mutate and return in more virulent form when the Northern Hemisphere enters its flu season later in the year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Shire to expand assistance program for UC patients

BY Alaric DeArment

PHILADELPHIA A British drug maker announced Monday that it would expand its patient assistance program for patients with ulcerative colitis.

Shire said that UC patients taking Lialda (mesalamine delayed-release tablets) or Pentasa (mesalamine extended-release capsules) and who became unemployed this year can receive their medication at no cost throughout the rest of the year.

“We are committed to helping UC patients better manage their condition,” Shire gastrointestinal business SVP Roger Adsett stated. “Offering greater financial support to those who may be struggling due to the current economic climate through our expanded Shire CARES PAP is a natural extension of the Shire mission.”

Last week, Pfizer announced that it would begin offering drugs for free to patients with prescriptions to Pfizer drugs who lost their jobs this year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?